Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2017 · 10-Q
Revenue$209.96M$209.96M−1.6% vs Q1 2016 Net Income-$10.35M-$10.35MN/M vs Q1 2016 EPS Diluted-$0.20-$0.20N/M vs Q1 2016 Gross Profit$91,056,000−11.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$30,695,000+231.8% Free Cash Flowderived$8,216,000N/M Margins · derivedGross margin43.4%−4.7 pt vs Q1 2016
Operating margin-3.8%−5.4 pt vs Q1 2016
Net margin-4.9%−4.8 pt vs Q1 2016
ended Jul 2, 2016 · filed Aug 1, 2016 · 30 d after period end